Yang Yin Fu Zheng Jie Du Therapy in HBV Associated Hepatocellular Carcinoma Based on the Platelet Count/Splenic Length-Diameter Ratio
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Fu Zheng Jie Du Hua Yu Principle For Treatment Of Severe HBV Related Hepatocellular Carcinoma (FZJDHYPFTOSHBVHCC)
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Prospective Cohort Study of Changes in Circulatory MicroRNA of Resected Hepatocellular Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Regorafenib After Progression on Atezolizumab Plus Bevacizumab in Advanced HCC
- Status
- UNKNOWN
- Phase
- PHASE2
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Influence of Social Determinants of Health on the Management of HCC in the French National Cohort Study CHIEF
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pressure-enabled Delivery in Radioembolization (TriNav Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
The Efficacy and Safety of HAIC With FOLFOX vs Sorafenib for Patients Who Showed TACE-resistant: a Retrospective Study
- Status
- COMPLETED
- Phase
- NA
BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment
- Status
- UNKNOWN
- Phase
- PHASE4
Neoadjuvant and Adjuvant Lenvatinib in HCC Patients Treated by Percutaneous Ablative
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Holmium-166 Retrospective Collection of Real-World Data
- Status
- COMPLETED
- Phase
- N/A
TQB2450 Plus Anlotinib as Adjuvant Therapy in HCC Patients at High Risk of Recurrence After Resection
- Status
- UNKNOWN
- Phase
- PHASE2
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Predictive Power of Share Wave Fibro Scan in HCC After HCV Infection
- Status
- COMPLETED
- Phase
- N/A
Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)
- Status
- COMPLETED
- Phase
- PHASE2